Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arash Radfar

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2008
Effects of high-dose IFNalpha2b on regional lymph node metastases of human melanoma: modulation of STAT5, FOXP3, and IL-17Wenjun Wang, Howard D Edington, Uma N M Rao, et al.
Journal of the American Academy of Dermatology|April 9, 2020
Importance of pathology review to complement clinical management of melanomaMeghan Beatson, Misty G Eleryan, Jeave Reserva, et al.
Journal for Immunotherapy of Cancer|October 2, 2021
PET/CT scan and biopsy-driven approach for safe anti-PD-1 therapy discontinuation in patients with advanced melanomaGeoffrey T Gibney, Jacob Zaemes, Shelly Shand, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2008
Effects of high-dose IFNalpha2b on regional lymph node metastases of human melanoma: modulation of STAT5, FOXP3, and IL-17Wenjun Wang, Howard D Edington, Uma N M Rao, et al.
Journal of the American Academy of Dermatology|April 9, 2020
Importance of pathology review to complement clinical management of melanomaMeghan Beatson, Misty G Eleryan, Jeave Reserva, et al.
Journal for Immunotherapy of Cancer|October 2, 2021
PET/CT scan and biopsy-driven approach for safe anti-PD-1 therapy discontinuation in patients with advanced melanomaGeoffrey T Gibney, Jacob Zaemes, Shelly Shand, et al.
Pageof 3